Form 4 for BMY Bristol Myers Squibb
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001753055-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-27 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +3,286 | 18.3K | +22% | $0 |
| D | 2026-03-03 | 2026-02-27 | BMY | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $62.37 | -1,672 | 16.7K | -9% | -$104.3K |
| D | 2026-03-03 | 2026-02-27 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | -3,286 | 3,286 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2026-02-27 | M | A | 3,286 | $0.00 | 18,344 | D | — | — | (F1) The restricted stock units vest in three equal installments beginning on March 1, 2025. |
| 2 | Common | Common Stock, $0.10 par value | 2026-02-27 | F | D | 1,672 | $62.37 | 16,672 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of award. |
| 3 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 3,286 | $0.00 | 3,286 | D | — · — to 2027-03-01 | 3,286 Common Stock, $0.10 par value | (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock units vest in three equal installments beginning on March 1, 2025. |